22157.jpg
Insights on the Cancer Biological Toxins Drug Global Market to 2026 - by Phase, Status, Cancer Type and Countries
February 04, 2021 07:48 ET | Research and Markets
Dublin, Feb. 04, 2021 (GLOBE NEWSWIRE) -- The "Global Cancer Biological Toxins Drug Market Opportunity, Drug Sales & Clinical Trials Insight 2026" report has been added to...
22157.jpg
Global Biologics Market Opportunities and Strategies Report 2020-2030: Route of Administration, Drug Classification, Mode of Purchase, Distribution Channel
February 03, 2021 05:13 ET | Research and Markets
Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Biologics Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering....
VIR_logo_large.jpg
Vir Biotechnology Announces New Data Highlighting the Importance of Targeting Conserved Regions of the SARS-CoV-2 Spike Protein in the Development of Therapeutics
February 01, 2021 08:00 ET | Vir Biotechnology, Inc.
– Scientists continuing to advance critical research on mechanisms of immune evasion exemplified by emerging SARS-CoV-2 variants – – Study identifies the N-terminal domain of the SARS-CoV-2 spike...
VIR_logo_large.jpg
Lilly, Vir Biotechnology and GSK Announce First Patient Dosed in Expanded BLAZE-4 Trial Evaluating Bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19
January 27, 2021 06:45 ET | Vir Biotechnology, Inc.
INDIANAPOLIS, SAN FRANCISCO and LONDON, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Eli Lilly and Company (NYSE: LLY), Vir Biotechnology, Inc. (NASDAQ: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today...
VIR_logo_large.jpg
Initial Data from Ongoing Phase 1 Trial of VIR-3434 for Chronic Hepatitis B Virus Infection Demonstrates Significant and Rapid Reduction in Hepatitis B Surface Antigen
January 26, 2021 08:00 ET | Vir Biotechnology, Inc.
– Novel HBV-neutralizing monoclonal antibody with therapeutic vaccine potential demonstrated a mean HBsAg reduction from baseline of 1.3 log10 IU/mL by day eight – SAN FRANCISCO, Jan. 26, 2021 ...
22157.jpg
Global Advanced Antibodies Report 2020 with Profiles of Key Companies - Advances in Antibody-based Therapies, Bispecific Antibodies (bsAbs) have Gained Momentum
January 21, 2021 07:03 ET | Research and Markets
Dublin, Jan. 21, 2021 (GLOBE NEWSWIRE) -- The "Advanced Antibodies, 2020" report has been added to ResearchAndMarkets.com's offering. This report profiles companies (excluding Tier 1...
22157.jpg
Global Protein Therapeutics Market (2020 to 2026) - Industry Analysis, Trends, Market Size, and Forecasts
January 14, 2021 12:08 ET | Research and Markets
Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The "Protein Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Life Science Tools and Reagents Market Report 2020: Data from 2018, 2019, 2020, and CAGR Projections Through 2025
January 13, 2021 09:53 ET | Research and Markets
Dublin, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The "Life Science Tools and Reagents: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report provides a detailed...
22157.jpg
Global Biotechnology Services Market Report 2020-2030: COVID-19 Impacts, Growth and Changes
January 06, 2021 12:03 ET | Research and Markets
Dublin, Jan. 06, 2021 (GLOBE NEWSWIRE) -- The "Biotechnology Services Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Global Research Antibodies and Reagents Market Report 2020-2027: Significant Opportunities from Emerging Asia-Pacific and Latin-American Markets
December 31, 2020 03:18 ET | Research and Markets
Dublin, Dec. 31, 2020 (GLOBE NEWSWIRE) -- The "Research Antibodies and Reagents Market by Product {Antibodies [Type (Primary, Secondary), Production, Source, Research Area (Oncology, Neurology)],...